Key Events This Week
16 Mar: Stock hits 52-week low near Rs.330.05 amid continued downtrend
19 Mar: Valuation shifts from expensive to fair as sector volatility persists
20 Mar: Week closes at Rs.332.95, down 5.68% for the week
Mar 30
BSE+NSE Vol: 2.6 lacs

Despite a broadly recovering market, FDC Ltd has slipped to a fresh 52-week low of Rs 314.75 on 30 Mar 2026, marking a continuation of its recent downward trajectory with a 3-day losing streak and a 3.8% decline over this period.
Read full news article
16 Mar: Stock hits 52-week low near Rs.330.05 amid continued downtrend
19 Mar: Valuation shifts from expensive to fair as sector volatility persists
20 Mar: Week closes at Rs.332.95, down 5.68% for the week

FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
While the broader market has shown signs of recovery, FDC Ltd has continued its downward trajectory, hitting a fresh 52-week low of Rs 318.1 on 27 Mar 2026. This decline comes amid a backdrop of underwhelming financial performance and waning institutional support, raising questions about the stock’s near-term outlook.
Read full news article
FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change comes amid a backdrop of subdued stock performance and challenging sector dynamics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.
Read full news article
FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 18 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
FDC Ltd, a player in the Pharmaceuticals & Biotechnology sector, has declined to a fresh 52-week low, closing near Rs 330.05, marking a significant point in its recent price trajectory. The stock’s performance reflects ongoing pressures, with a notable underperformance relative to its sector and broader market indices.
Read full news articleIntimation of Closure of trading window
General update
Please find attached Announcement under Regulation 30( LODR) 2015 Pertaining to Change in Directorate.
No Upcoming Board Meetings
FDC Ltd has declared 500% dividend, ex-date: 11 Feb 26
No Splits history available
No Bonus history available
No Rights history available